Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Sudden Cardiac Arrest Risk Factors in Patients With CAD - CVDLINK Clinical Validation Study.

NCT07444931 is registered in ClinicalTrials.gov with Tampere Heart Hospital as lead sponsor.

NCT NCT07444931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07444931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Sudden Cardiac Arrest Risk Factors in Patients With CAD - CVDLINK Clinical Validation Study.
Lead sponsor
Tampere Heart Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 5, 2025
Completion date
December 31, 2027
Enrollment
1,500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterial disease (cad), sudden cardiac arrest, sudden cardiac death